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A loss of functionmutation in the TRESKK2P potassium channel (KCNK18), has recently been linked with
typical familial migraine with aura. We now report the functional characterisation of additional TRESK
channel missense variants identified in unrelated patients. Several variants either had no apparent
functional effect, or they caused a reduction in channel activity. However, the C110R variant was found to
cause a complete loss of TRESK function, yet is present in both sporadic migraine and control cohorts, and
no variation in KCNK18 copy number was found. Thus despite the previously identified association
between loss of TRESK channel activity and migraine in a large multigenerational pedigree, this finding
indicates that a single non-functional TRESK variant is not alone sufficient to cause typical migraine and
highlights the genetic complexity of this disorder.
M
igraine is a common, disabling neurological disorder with a genetic, environmental and in some cases
hormonal component. It is characterized by attacks of severe, usually unilateral and throbbing headache,
can be accompanied by nausea, vomiting and photophobia and is clinically divided into two main
subtypes, migraine with aura (MA)when amigraine is accompanied by transient and reversible focal neurological
symptoms and migraine without aura (MO)1. The multifactorial and clinical heterogeneity of the disorder have
considerably hindered the identification of common migraine susceptibility genes and most of our current
understanding comes from the studies of familial hemiplegic migraine (FHM), a rare monogenic autosomal
dominant form of MA2.
So far, the three susceptibility genes that have been convincingly identified in FHM families all encode ion
channels or transporters: CACNA1A encoding the a1 subunit of the Cav2.1 calcium channel3, SCN1A encoding
the Nav1.1 sodium channel4 and ATP1A2 encoding the a2 subunit of the Na1/K1 pump5. It is believed that
mutations in these genes may lead to increased efflux of glutamate and potassium in the synapse and thereby
cause migraine by rendering the brain more susceptible to cortical spreading depression (CSD)6 which is thought
to play a role in initiating a migraine attack7,8. However, these genes have not to date been implicated in common
forms of migraine9.
Nevertheless, current opinion suggests that typical migraine, like FHM, is also disorder of neuronal excit-
ability, ion homeostasis and neurotransmitter release10–12. Mutations in the SLC4A4 gene encoding the sodium-
bicarbonate cotransporter NBCe1, have recently been implicated in several different forms of migraine13, and a
variety of genes involved in glutamate homeostasis (PGCP,MTDH14 and LRP115) and a cation channel (TRPM8)15
have also recently been implicated in migraine via genome-wide association studies. Ion channels are therefore
highly likely to play an important role in the pathogenesis of typical migraine.
TRESK (KCNK18), is a member of the two-pore domain (K2P) family of potassium channels involved in the
control of cellular electrical excitability16. Regulation of TRESK activity by the calcium-dependent phosphatase
calcineurin17, as well as its expression in dorsal root ganglia (DRG)18 and trigeminal ganglia (TG)19,20 has led
to a proposed role for this channel in a variety of pain pathways. In a recent study, a frameshift mutation
(F139Wfsx24) in TRESK was identified in a large multigenerational pedigree where it co-segregated perfectly
with typical MA and a significant genome-wide linkage LOD score of 3.0. Furthermore, functional analysis
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revealed that this mutation caused a complete loss of TRESK func-
tion and that the truncated subunit was also capable of down regu-
lating wild-type channel function. This therefore highlightedKCNK18
as potentially important candidate gene and suggested that TRESK
dysfunction might play a possible role in the pathogenesis of familial
migraine with visual aura20.
Additional screening for KCNK18mutations in unrelated sporadic
migraine and control cohorts also identified a number of other mis-
sense variants; R10G, A34V, C110R, S231P and A233V20. The A233V
variant was found only in the control cohort, whilst A34V was iden-
tified in a single Australian migraine proband for which family
samples were not available, but it was not detected in controls. By
contrast, the R10G, C110R, and S231P variants were found in both
migraineurs and controls in both cohorts. In this study, we have in-
vestigated the functional effect of these variants to further probe the
potential association of TRESK dysfunction with typical migraine.
Results
Location of missense variants in the TRESK channel. The pre-
dicted location of these variants in the TRESK channel is shown
in Figure 1; R10G is located within the N-terminus, A34V within
the first transmembrane domain (TM1) and C110R close to the
selectivity filter in first pore domain (P1). The S231P and A233V
variants are both located within the intracellular loop between TM2
and TM4. This domain acts as the site for regulation by calcineurin
and both the S231P and A233V variants occur directly between two
motifs involved in this process; the nuclear factor of activated T cells
(NFAT)-like docking motif, PQIIIS, and the 14-3-3 binding motif,
RSNSCP17,21,22.
There are currently no crystal structures available for K2P chan-
nels and so we mapped the position of these variants using a homo-
logy model of the TRESK channel pore (Figure 1B). Only the A34
and C110 residues are included in this structure because there are no
templates for the intracellular domain. Interestingly, the model pre-
dicts that A34 in TM1 is in contact with C110 in the pore-helix and
that both residues are adjacent to the selectivity filter which has
recently been implicated in the control of K2P channel gating23.
Functional properties of missense variants.We next examined the
effect of these different variants on the functional properties of
TRESK. Figure 1C shows representative whole-cell basal currents
recorded from oocytes expressing either wild-type (WT) or mutant
Figure 1 | Basal currents of missense variants identified in TRESK. (A) Schematic topology of the human K2P TRESK subunit showing the position of
the identified missense variants. (B) Side view of homology model of the TM/pore domains of TRESK with the A34 and C110 residues shown in blue and
red respectively. For clarity only the P1 domain is shown. (C) Representative whole-cell currents from an oocyte expressing either WT TRESK or the
variants. Oocytes were bathed in lowK solution, the membrane potential held at 280 mV and voltage steps from 2120 to 160 mV applied for 1 sec in
20 mV increments. (D)Normalised basal currents for the TRESK variants. Steady state currents weremeasured at the end of the 1s pulse to160 mV from
the whole cell currents (as shown in C). For each batch of oocytes, the currents were normalised to the average of control group. Data were pooled from 2
to 4 batches. Oocytes were injected with 0.9 ng of RNA except for the C110R mutant where 4.5 ng was injected. N-numbers are given above the bars.
www.nature.com/scientificreports
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TRESK. WT TRESK exhibited large outwardly-rectifying whole
cell K1 currents similar to those previously reported24,25. Currents
recorded from the R10G, S231P and A233V variants appeared
almost indistinguishable to WT currents and were similar in mag-
nitude (Figure 1D). By contrast, the A34V mutant expressed mark-
edly reduced currents compared to WT TRESK, whilst currents
recorded from oocytes expressing the C110R mutant channel were
indistinguishable from those of uninjected controls (Figure 1D).
Even though the S231P and A233V mutants had no apparent
effect on the magnitude of the basal current levels, their close prox-
imity to important regulatory sites suggests that they may interfere
with the calcineurin-dependent regulation of TRESK. Similarly, even
though the A34V and C110R variants expressed little or no basal
currents, they may still be capable of responding to calcineurin
activation. It has been shown that an increase of intracellular calcium
produced by the calcium ionophore ionomycin, can produce calci-
neurin-dependent activation of TRESK expressed in Xenopus
oocytes17. We therefore determined the effect of ionomycin on these
different TRESK variants (Figure 2). As shown previously, 500 nM
ionomycin induced a large, robust and reversible activation of WT
TRESK17. Ionomycin also activated the R10G, S231P and A233V
variants and the extent of this activation did not differ significantly
from that of theWT channel (Figure 2B). By contrast, the response of
the A34V and C110R variants to ionomycin was essentially unde-
tectable and similar to the background currents activated by iono-
mycin in control oocytes26.
Loss of TRESK function in the A34V and C110R variants. Al-
though very small, some residual current could be detected for the
A34V variant (Figure 1) andwe found that when greater quantities of
mRNA (4.5 ng) were injected, larger currents could be recorded very
similar in profile to WT TRESK (Figure 3A). We also found that
despite the absence of calcineurin activation seen in Figure 1, when
these larger basal currents were recorded, ionomycin induced a
reversible activation similar to that of WT TRESK (Figure 3B).
This suggests that the A34V variant can still produce functional
channels, and that the mechanisms which underlie calcineurin
activation must therefore remain intact. By contrast, no basal cur-
rents or any response to ionomycin could be recorded from the
C110R variant even when larger quantities of mRNA (4.5 ng) were
injected (Figure 3C).
In our previous study we demonstrated that 151 coexpression
of the F139Wfsx24 mutant with WT TRESK (i.e. a situation that
mimics the heterozygous state) reduced WT channel activity20. We
therefore examined whether the loss-of-function phenotypes seen
with the C110R and A34V variants had a similar effect. Coin-
jection of WT and C110R mutant mRNAs in a 151 ratio reduced
the whole-cell currents by about 40% and further reduction was
observed when the ratio of C110R mRNA was increased (Figure 3C).
This suggests the C110R variant produces a completely non-functional
subunit, similar to the F139Wfsx24 mutation that shows a strong
genetic linkage tomigraine with aura. Similar results were also obtained
upon coexpression of WT and A34V mRNAs (Figure 3C). But the
effect was reduced when the relative amount of A34V mRNA was
increased, most likely because the A34V variant does not produce a
complete loss of function and can probably form functional hetero-
meric channels.
A34V forms functional heteromeric channels. To further explore
the properties of a heteromeric WT-A34V channel population we
created a tandemly linked dimer. The concatenation of subunits has
successfully been employed to control subunit stoichiometry in a
variety of different types of K1 channels, including several K2P
channels27,28. As a control, we first created a WT-WT dimer and
found that the basal currents and ionomycin activation of this
WT-WT tandem construct were virtually indistinguishable from
those of homomeric WT TRESK (Figure 4). Expression of the
WT-A34V tandem construct also resulted in TRESK-like currents
that could still be activated by ionomycin, but they were of sig-
nificantly smaller amplitude than the WT-WT dimer. This indi-
cates that the A34V variant is also capable of down-regulating WT
TRESK activity through coassembly as a dysfunctional heteromeric
channel.
KCNK18 gene copy number. Both A34V and C110R variants result
in a severe loss of TRESK function. Yet, while the A34V variant has
thus far been found only in one patient with migraine, the C110R
variant shows no genetic association withMA. In an Australian case-
control cohort, the C110R variant was present in 12 unaffected
individuals of a total 496, compared with 8 affected individuals of
a total 47920. Variations in gene copy number have been implicated
in several genetic diseases and pathological conditions, including
several K2P channel genes29. We therefore assessed KCNK18 copy
number variation (CNV) in individuals with and without migraine.
However, we found that all individuals with the C110R variant have
the expected two copies of KCNK18 irrespective of their migraine
status (Figure 5).
Figure 2 | Response of TRESK variants to ionomycin. (A) Representative
current responses to 500 nM ionomycin. Plotted current values represent
measurements taken at the end of 300-ms voltage steps to 2100 mV
applied every 3 s from a 0-mVholding potential. As shown above the trace,
oocytes were switched from lowK to highK solution prior to the
application of ionomycin. (B) Normalised responses to ionomycin. The
current measured after ionomycin activation was normalised to the
current measured before activation in each oocyte. Oocytes were injected
with 0.13 ng RNA. N-numbers are given within the bars.
www.nature.com/scientificreports
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Discussion
This functional analysis of missense variants in the KCNK18
gene provides an important insight in the pathogenesis of typical
migraine. Whilst our previous report supports a causative role for
the F139Wfsx24 loss of function mutation in the KCNK18 gene
in familial migraine MA20, the data presented here suggest a more
complex association of other loss of function variants with typical
migraine.
The R10G, S231P and A233V variants had no obvious effect on
TRESK activity consistent with their identification in both control
and migraine cohorts. Indeed, the A233V variant has already been
reported in the Single Nucleotide PolymorphismDatabase (rs363360)
and has been shown to be common (minor allele frequency 5 0.15)
in African populations. However, for the two mutants (A34V and
C110R) which did show a loss of TRESK function, their association
with typical migraine is unclear. The A34V variant was indeed found
in an unrelated proband diagnosed with typical migraine and was
absent in all controls tested20. However, the C110R variant appears to
show no genetic association with typical migraine.
The complete loss of function seen in C110R variant is perhaps
not surprising as this residue is located adjacent to the selectivity
filter where substitution with an arginine is likely to be disruptive
to channel function. Interestingly, both the A34 and C110 residues
are located close to one another and the selectivity filter has recently
been implicated in the control of K2P channel gating30. Whether
these mutations lead to an intrinsic loss of function and/or impair
channel trafficking, the functional consequences appear the same i.e.
a reduction in TRESK channel activity. Furthermore, both A34V and
C110R variants, like the F139Wfsx24 variant, appear to have the
ability to interact with, and reduce the activity of coexpressed WT
TRESK. Therefore in the heterozygous state, in addition to any
intrinsic loss of function, both variants could further reduce TRESK
activity through coassembly with WT subunits. In other K1 channe-
lopathies e.g. Episodic Ataxia Type 1, non-functional mutant subunits
also reduce channel activity through ‘dominant-negative’ coassembly
with WT subunits and often result in .90% suppression of channel
activity31–33. However, in contrast to tetrameric channels, the assembly
of K2P channels as a dimer of dimers means that any dominant
negative effect will always be far less severe, because even if the
mutant subunit can coassemble withWT subunits at least 25% homo-
meric WT channels will remain. Consequently, for K2P channels in
particular, any potential relationship between a dominant inheritance
pattern and a dominant negative effect on channel function may be
difficult to interpret.
Figure 3 | Loss of function in the A34V and C110R variants. (A) Representative whole cell currents from an oocyte expressing a larger quantity of A34V
mRNA (4.5 ng). (B) Representative current responses to 500 nM ionomycin of an oocyte expressing a larger quantity A34V mRNA (4.5 ng).
(C) Normalised peak currents measured at 120 mV for WT TRESK coexpressed with either the A34V or C110R variants. Molar ratios, indicated above
the bars, are 15150.45 ng:0.45 ng; 55552.5 ng:2.5 ng; 15550.45 ng:2.5 ng. N-numbers are given within the bars.
www.nature.com/scientificreports
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Figure 4 | A34V forms functional heteromeric channels withWTTRESK. (A) Representative basal current and (B) Representative response to 1 mMfor
the WT-WT tandem channel. (C) Representative basal current and (D) Representative response to 1 mM for the WT-A34V tandem channel.
Figure 5 | Predicted copy number values for KCNK18. All samples showed a normal predicted copy number value of 2. No differences were seen between
C110R migraineurs (red bars) and C110R non-migraineurs (blue bars). Error bars represent the maximum and minimum limits based on the technical
replicates for each sample.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 237 | DOI: 10.1038/srep00237 5
Our observation that some unaffected individuals appear to carry
quite deleterious mutations obviously questions a simple direct cau-
sative link between defective TRESK function and typical migraine.
Differences in KCNK18 copy number variation cannot account for
our original observation, because all individuals with the C110R
mutation have the expected two copies of KCNK18 irrespective of
their migraine status. Genomic imprinting is also unlikely as both
maternal and paternal transmission is observed20. Perhaps the most
likely explanation is that migraine is now widely accepted as a com-
plex polygenic disorder, even in the case of apparently Mendelian
segregation34, and is therefore undoubtedly dependent upon the
interplay of multiple genes as well as gene-environment interac-
tions9. In other complex disorders of neuronal excitability e.g. epi-
lepsy, a recent report suggested that even deleterious ion channel
mutations conferred uncertain risk to an individual and this risk
was highly-dependent on other variants with which they are com-
bined35. Such considerations are now becoming typical of the chal-
lenges required to link a disease-causing role to an inherited variant
in a single ion channel, despite the overwhelming evidence thatmany
common neurological disorders are associated with ion channel
dysfunction36,37.
In conclusion, if the influence of TRESK on TG neuronal excit-
ability does indeed play a role in the pathogenesis of migraine then its
effects are undoubtedly complex. These results demonstrate that
despite the significant genetic linkage of the F139Wfsx24 variant in
an extended MA family, the presence of a single non-functional
variant is probably not alone sufficient to determine whether an
individual develops migraine. This further highlights the importance
of understanding the broader genetic background of any affected
individual.
Methods
Molecular Biology.Human TRESK was subcloned between the 5’ and 3’ UTR of the
Xenopus b-globin gene in the oocyte expression vector, pBF. The R10G, A34V,
C110R, S231P and A233V mutants were made by site directed mutagenesis and
confirmed by automated sequencing. Wild type andmutant tandem linked dimers of
TRESK were made using extension overlap PCR which deleted the stop codon of the
first subunit and introduced a Gly(Gln)10Gly linker immediately prior to the first
methionine of the second TRESK subunit. mRNA for wild-type, mutant and tandem
linked dimeric channels was synthesized using the SP6mMESSAGEmMACHINE kit
(Ambion) and mRNA concentrations were quantified by spectrophotometric
analysis prior to injection.
Electrophysiological recordings. Unless otherwise stated, equal quantities of either
wild-type or mutant mRNAs were microinjected into defolliculated Xenopus oocytes
according to standard protocols. Whole-cell currents were recorded 18–24 hours
after injection, at room temperature (20–22uC), using the two-electrode voltage
clamp method (Geneclamp 500B, Axon Instruments). Oocytes were held in a small
recording chamber and were continuously perfused with control extracellular
solution, lowK (in mM: 95.4 NaCl, 2 KCl, 1.8 CaCl2, 5 HEPES pH 7.5 with NaOH)
using a pump driven perfusion system. Recording electrodes were back-filled with 3M
KCl and their resistances varied from 0.3 to 1 MV. Currents were filtered at 100 Hz
and digitised at 1 kHz for analysis. Oocytes were held at280 mV, voltage commands
were applied, and currents were recorded using pClamp 9 software (Axon
Instruments). TRESK currents were usually measured in lowK solution, at the end of
1 second long voltage steps from a holding potential of 280 mV delivered in 20 mV
increments from 2120 mV to 160 mV. For the experiments with ionomycin,
TRESK currents were measured in highK solution (in mM: 17.4 NaCl, 80 KCl, 1.8
CaCl2, 5 HEPES, pH 7.5 with NaOH) at the end of 300 ms-long voltage steps from
0 mV to 2100 mV. Ionomycin (free acid form), was made as a stock solution of
5 mM in dimethyl sulphoxide and diluted in the highK solution to the appropriate
test concentration (0.5 mM or 1 mM for activation of tandem dimers) on the day of
the experiment. Data were analysed with pCLAMP9 (Axon instruments).
Homology Modelling. To build a structure of the TRESK channel pore, the
extracellular and intracellular loops were omitted due to a lack of homology with any
known structural template. The secondary structure and transmembrane topology
for TRESK (Q7Z418) was predicted using the PSI-Prediction server (http://
bioinf.cs.ucl.ac.uk/psipred/). KvAP (PDB 1ORQ) was chosen as the primary
structural templates for the TRESK homology models and ClustalX used to align two
copies of the KvAP sequence modified to resemble a dimer. Alignments were
generated conserving key features such as the selectivity filter, glycine-hinge (in M2
and M4) and glutamate residues at the top of M1 and M3 helices. The homology
models of TRESKwere created usingModeller 9v8. For each set of ten TRESKmodels
generated, the lowest energy model was selected.
Copy number values for KCNK18. A known copy number variation (CNV)
identified in a Micronesian control cohort overlaps the second exon and first and
second introns of KCNK18 (Gusev et al. 2009GenomeRes. 19:318–26.). The presence
of this CNV was analyzed in genomic DNA from 20 individuals with and without
migraine with the C110R variant from the Australian case-control cohort using an
Applied Biosystems TaqMan Copy Number Assay. The KCNK18 CNV assay (Assay
ID: Hs00964672_cn) was run along with the recommended control assay taken from
a region devoid of CNVs (RnaseP). Triplicate assays were run on the AB 7900HT
System under standard conditions according to the manufacturer’s protocol. Data
was analysed using CopyCaller Software (v1.0 Applied Biosystems).
Statistics.Data are given as mean values 6 standard error of the mean (SEM), where
n represents the number of oocytes. Results were reproducible in at least 2–3 different
batches of oocytes. Statistical significance was determined using a student’s t-test.
When error bars are not shown they are smaller than the size of the symbol.
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